Increase in the incidence of tuberculosis in developing countries and rise in awareness about the disease are driving growth of the tuberculosis diagnostics market.
Market Size – USD 2.58 Billion in 2019, Market Growth – CAGR of 4.2%, Market Trends –Advancements in technology
The global tuberculosis diagnostics market is expected to reach a market size of USD 3.58 Billion by 2027 and register a high revenue growth rate during the forecast period, according to a new report by Reports and Data. Growing incidence of tuberculosis is a major factor driving growth of the tuberculosis diagnostics market.
According to the World Health Organization (WHO), every year, 8.8 million new cases of tuberculosis are found and approximately 2 million deaths are caused by the disease. Resistance to multiple drugs among patients suffering from tuberculosis is another key point of concern.
Rise in initiatives by governments and independent organizations to control the spread of tuberculosis is also contributing to growth of the global tuberculosis diagnostics market. Various organizations are trying to create awareness regarding the infectious disease, especially in underdeveloped countries, to limit the disease spread. over the years due to rapid and reliable results. This limits growth of the global tuberculosis diagnostics market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3742
Leading companies operating in the market and profiled in the report include:
Alere Inc., F.Hoffmann-La Roche AG, Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Siemens, Hologic Corporation, Cepheid, Hain Lifesciences GmbH, and Thermo Fisher Scientific Inc.
Dominant key players in the market are adopting various strategies like mergers and acquisition, partnerships, collaborations, joint ventures and product launches to gain a robust footing in the market. Growing demand for various medical products, increasing adoption of home-care settings, point-of-care diagnosis, high demand for vaccines and medication for controlling COVID-19 is expected to benefit the key companies throughout the forecast period.
Global Tuberculosis Diagnostics Market Segmentation:
Disease Stage Outlook (Revenue, USD Billion; 2017-2027)
- Latent Tuberculosis
- Active Tuberculosis
Test Type Outlook (Revenue, USD Billion; 2017-2027)
- Radiographic Method
- Cytokine Detection Assay
- Nucleic Acid Testing
- Detection of Latent Infection
- Diagnostic Laboratory Method
- Detection of Drug Resistance
End-use Outlook (Revenue, USD Billion; 2017-2027)
- Research Institutes & Academics
- Reference Laboratories
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3742
The global Tuberculosis Diagnostics market is broadly divided into 5 major regions, viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3742
Thank you reading our reading. Kindly note that we also offer customized report as per client’s requirement. Feel free to contact us to know more about the customization feature and get your customized report.
Browse More Reports: